Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review

Cholangiocarcinoma is a group of malignancies with poor prognosis. Treatments for the management of advanced-stage cholangiocarcinoma are limited, and the 5-year survival rate is estimated to be approximately 5–15%, considering all tumor stages. There is a significant unmet need for effective new tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vignone, Anthony, Biancaniello, Francesca, Casadio, Marco, Pesci, Ludovica, Cardinale, Vincenzo, Ridola, Lorenzo, Alvaro, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584870/
https://www.ncbi.nlm.nih.gov/pubmed/34768421
http://dx.doi.org/10.3390/jcm10214901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584870/
https://www.ncbi.nlm.nih.gov/pubmed/34768421
http://dx.doi.org/10.3390/jcm10214901

Ejemplares similares